CiPPPA is a collaborative not-for-profit initiative that connects stakeholders across the entire pharmaceutical supply chain to develop and deploy solutions for recycling of primary pharmaceutical packaging.
The initiative seeks to revolutionise the primary pharmaceutical packaging industry by championing sustainable practices, fostering collaboration and commitment, and developing solutions free from competition, for the benefit of all.
CiPPPA’s Action Task Forces – focusing on blister, inhaler, and injectable packaging – are pivotal in driving the initiative forward. Led by industry experts, their aim is to leverage and optimise existing solutions for pharmaceutical packaging – scaling them for use nationally.
CiPPPA aims to reshape the management of pharmaceutical packaging and lead the healthcare industry in environmental stewardship. Join us in this groundbreaking initiative to contribute to industry-wide transformation.
When it comes to protecting medicines and ensuring their efficacy, polyvinyl chloride (PVC) has been a common choice for over-the-counter (OTC) medicine packaging in the UK and Europe due to its protective properties and cost-effectiveness. However, recent trends indicate a potential shift away from PVC, driven by environmental concerns and recycling challenges.
In the pharmaceutical industry, packaging innovation is important in ensuring drug effectiveness, patient compliance, and environmental sustainability. CiPPPA members are working to be at the forefront of this innovation, focusing on three key areas: inhalers, blister packs, and injectables.
At the recent Pharmapack 2025 event in Paris, industry leaders gathered to discuss issues in pharmaceutical packaging. Among the notable presentations was a session by Duncan Flack, Chairman of CiPPPA, who addressed the complex landscape of sustainability in hard-to-recycle packaging formats.